These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

196 related items for PubMed ID: 7705600

  • 1. [Value of the adenosine triphosphate chemosensitivity assay for pre-therapeutic determination of the chemosensitivity of breast cancer cells in cell culture].
    Köchli OR, Sevin BU, Schär G, Haller U.
    Geburtshilfe Frauenheilkd; 1995 Jan; 55(1):7-16. PubMed ID: 7705600
    [Abstract] [Full Text] [Related]

  • 2. [-Chemosensitivity testing in gynecologic oncology. Experiences with an ATP bioluminescence assay-].
    Kurbacher CM, Mallmann P, Kurbacher JA, Hübner H, Krebs D.
    Geburtshilfe Frauenheilkd; 1996 Feb; 56(2):70-8. PubMed ID: 8647362
    [Abstract] [Full Text] [Related]

  • 3. In vitro chemosensitivity in breast cancer using ATP-tumor chemosensitivity assay.
    Qi CJ, Ning YL, Zhu YL, Min HY, Ye H, Qian KQ.
    Arch Pharm Res; 2009 Dec; 32(12):1737-42. PubMed ID: 20162402
    [Abstract] [Full Text] [Related]

  • 4. [Application of a micromethod in ovarian cancer chemosensitivity testing in vitro].
    Liu S, Qian X, Peng Z, Wang H.
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2003 Apr; 34(2):298-9, 312. PubMed ID: 12947719
    [Abstract] [Full Text] [Related]

  • 5. [A new chemosensitivity test for cancer cells by measuring intracellular ATP content].
    Nogaki M, Ichihashi H.
    Nihon Geka Gakkai Zasshi; 1988 Dec; 89(12):1950-6. PubMed ID: 3231205
    [Abstract] [Full Text] [Related]

  • 6. Evaluation of new drugs and combinations in gynecologic tumors and cancer cell lines with the ATP-cell viability assay.
    Untch M, Sevin BU.
    Contrib Gynecol Obstet; 1994 Dec; 19():145-55. PubMed ID: 7995046
    [No Abstract] [Full Text] [Related]

  • 7. Heterogeneity of chemosensitivity in human breast carcinoma: use of an adenosine triphosphate (ATP) chemiluminescence assay.
    Hunter EM, Sutherland LA, Cree IA, Dewar JA, Preece PE, Wood RA, Linder D, Andreotti PE.
    Eur J Surg Oncol; 1993 Jun; 19(3):242-9. PubMed ID: 8314382
    [Abstract] [Full Text] [Related]

  • 8. Potential use of the adenosine triphosphate cell viability assay in endometrial cancer.
    Tam KF, Ng TY, Tsang PC, Li CF, Ngan HY.
    J Soc Gynecol Investig; 2006 Oct; 13(7):518-22. PubMed ID: 16979354
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Application of the adenosine triphosphate-cell viability assay in human breast cancer chemosensitivity testing: a report on the first results.
    Koechli OR, Avner BP, Sevin BU, Avner B, Perras JP, Robinson DS, Averette HE.
    J Surg Oncol; 1993 Oct; 54(2):119-25. PubMed ID: 8412158
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Comparative chemosensitivity profiles in three human breast cancer cell lines with the ATP-cell viability assay.
    Koechli OR, Sevin BU, Perras JP, Angioli R, Untch M, Steren A, Ramachandran C, Averette HE.
    Oncology; 1994 Oct; 51(6):552-8. PubMed ID: 7970502
    [Abstract] [Full Text] [Related]

  • 15. Correlation of drug response with the ATP tumorchemosensitivity assay in primary FIGO stage III ovarian cancer.
    Konecny G, Crohns C, Pegram M, Felber M, Lude S, Kurbacher C, Cree IA, Hepp H, Untch M.
    Gynecol Oncol; 2000 May; 77(2):258-63. PubMed ID: 10785475
    [Abstract] [Full Text] [Related]

  • 16. The use of an in vitro adenosine triphosphate-based chemotherapy response assay to predict chemotherapeutic response in breast cancer.
    Kim HA, Yom CK, Moon BI, Choe KJ, Sung SH, Han WS, Choi HY, Kim HK, Park HK, Choi SH, Yoon EJ, Oh SY.
    Breast; 2008 Feb; 17(1):19-26. PubMed ID: 17659874
    [Abstract] [Full Text] [Related]

  • 17. [The evaluation of adenosine triphosphate bioluminescence assay for chemosensitivity testing of ovarian cancer cell line].
    Shi W, Gu M, Liang L.
    Zhonghua Fu Chan Ke Za Zhi; 1996 Feb; 31(2):79-82. PubMed ID: 8758798
    [Abstract] [Full Text] [Related]

  • 18. Clinical applicability of the ATP cell viability assay as a predictor of chemoresponse in platinum-resistant epithelial ovarian cancer using nonsurgical tumor cell samples.
    Ng TY, Ngan HY, Cheng DK, Wong LC.
    Gynecol Oncol; 2000 Mar; 76(3):405-8. PubMed ID: 10684718
    [Abstract] [Full Text] [Related]

  • 19. [Chemosensitivity studies with soft agar culture systems in ovarian cancer].
    Werner A, Krebs D, Diedrich K, Fimmers R, Heuer J, Oberheuser F.
    Geburtshilfe Frauenheilkd; 1990 Nov; 50(11):883-9. PubMed ID: 2283015
    [Abstract] [Full Text] [Related]

  • 20. Anticancer chemosensitivity profiles of human breast cancer cells assessed by in vitro DNA synthesis inhibition assay.
    Nio Y, Tamura K, Kan N, Inamoto T, Ohgaki K, Kodama H.
    Anticancer Res; 2000 Nov; 20(2B):1237-44. PubMed ID: 10810427
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.